Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05637099Completed

The Value of Repeated BIOMarker Measurements During an SBT to Predict EXtubation Failure in ICU Patients

Role: lead

NCT05906888Completed

Weaning With Tracheostomy - an Observational Study on Patient-centered Outcomes

Role: lead

NCT05403359Completed

StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands.

Role: lead

NCT05652699Not ApplicableCompleted

Effect of HFNO Therapy on Respiratory Effort After Extubation

Role: lead

NCT06776939Not ApplicableRecruiting

Physiological Effect High-flow Tracheal Oxygen on Viscosity of Airway Mucus and Respiratory Effort in Patients Weaning from Invasive Mechanical Ventilation

Role: lead

All 5 trials loaded